Hvem bestemmer teknologien der former dig og dit liv? 🎩 Burde du ikke have en stemme når andre bestemmer din fremtid? 💡 Vær med til at skabe fremtiden med Citizen Project! 🎉 Citizen Project består af et inkluderende designspil og en digital platform der giver almene borgere en stemme i det digitale tech-kapløb. Med Citizen Project kan alle og enhver blive opfinder af ny fremtidig teknologi og designvisioner.

imove tech recently rebranded to Casi - your car subscription technology provider. Say what? imove became two separate businesses; the consumer-facing car subscription service, which maintains the imove brand, and Casi Say what? imove became two separate businesses; the consumer-facing car subscription service, which maintains the imove brand, and Casi. Why the change? Because being a tech provider and operating a car subscription service are two very different business models. To allow both areas to scale and succeed, we created two separate brands and businesses. We took the insight of running imove with us into Casi, and through leading technology and know-how, we continue to enable scalable car subscription services that people love. The Casi crew is here to accelerate the car subscription segment by delivering technology that unleashes the power of your fleet.

The whole world is working remotely from home now. Desktop has moved the old desktop workspace from your PC into a browser that can be shared across people, teams, and companies. And Desktop.com provides a single sign-on (SSO) and a password manager so that each team members only have to remember one login password to desktop.com. In addition, Desktop.com has full chat and video conferencing so that all team members can work and communicate within the platform. On Desktop.com you can find and set up all your favorite applications. And as more and more application providers integrate with Desktop.com the community will grow and the service improve. Desktop.com is based on monthly subscriptions (SaaS).

Cycl works to solve plastic pollution by using available technology in a sensible way. Our vision is to give value to every single plastic and minimize plastic waste by 100% in all countries we operate in. Cycl is a mobile app that can tell our users about nearby recycling stations, when their bottle is recycled we make sure that they get rewarded for their work.

The Electrical Vehicle market in Norway is exploding and more than every 2nd car sold is now electric. With this also the accessories market is exploding. Besen Group AS is a "spinoff" from Grønne Mil AS which created the market standard for sales of electric vehicle accessories to consumers in Norway already in 2015. While Grønne Mil AS is a B2C business offering a wide scope of products, Besen Group AS is a local agent and distributor of the largest cables and charging station producer in China, Besen International Group AS. The aim is to cover the entire value chain with both Besen Group AS in Norway and Grønne Mil AS. Besen Group International in China is transferring customers for local handling and development.

EKKO MEDIA ER NORGES FØRSTE DIGITALE MEDIEBYRÅ SPESIALISERT MOT EIENDOMSMARKEDET.Ekko leverer digitale markedsføringsløsninger for eiendomsprosjekter og meglere i hele Norge. Vi har fokus på utvikling av ny teknologi for å alltid ligge langt foran konkurrentene. Byrået ble startet opp i 2013 av gründerne Lars Henrik Sand og Asgeir Brude Wærås. De opplevde at eiendomsbransjen var preget av byråer som var sterke på fagfelt som 3D eller nettsider, men de så et behov for spesialisering av digital markedsføring. På kort tid har byrået vokst til en meget sterk aktør innen digital markedsføring, hvor mye av grunnen til den sterke veksten er byråets nysgjerrighet, engasjement og serviceinnstilling. Med disse egenskapene er Ekko Media alltid med på å skape nye metoder, strategier og markedsanalyser – som igjen gir et unikt fortrinn i et marked som aldri står stille.

Gain visibility and control over your compliance processes with ease! Our integrated GDPR solution includes consent management, data discovery, documentation, audit logs, assessments, people and customer profiles, and much more. We give you a practical approach to GDPR and "Privacy by design". Get also an award-winning access portal that supports secure Single Sign-On access of data and easy setup of security policies. Mesier, The holistic approach to Cloud governance! Currently, we are 10 highly motivated people with extensive experience in making successful software. Let's talk!

Ose Water AS is a Norwegian bottled water and bag-in-box water producer.The water source is Ose which provides high quality natural mineral water. The company aim to be in production for international sale in Q1 2019. Ose Water AS is a producer of natural mineral water from the Ose spring in Bygland municipality, Aust-Agder county in Norway.

AVISOMO is developing indoor growing modules for farmers. These modules have an integrated regulation system that automatically cares for the environment inside and outside the module. The environment being nutrients in the hydroponic nutrient solution, pH levels, temperature, CO2 levels, light intensity and so on. This regulator is what makes this technology available to everyone. The regulation technology combined with top-shelf advanced LED makes our modules the best way to increase a farmer's yield more cost- and labour-effective.

RESPINOR is a privately-owned medical device company, founded in Oslo, 2015. We have developed an objective measure of breathing for critically ill patients within intensive care. The technology provides precise, continuous and real-time information of diaphragm function, our main breathing muscle, to increase the quality of care and reducing costs. RESPINOR’s technology is the winner of Horizon 2020 both in phase I and II. We are addressing an unmet medical need because every breath counts.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Jeg har jobbet innenfor biologisk medisin i 25 år.Vi har funnet et egnet sted i Sverige for å drive HELSE FARM med mange mulige aktiviteter...nære Oslo. Dersom du har "helsetanker" i forbindelse med dine innvesteringer, kontakt meg !TOTAL INVESTERING I DETTE PROSJEKTET ER 9 MILL NOKTa gjerne kontakt!CARL-ERIK FARNES90677330cefarnes@gmail.com

Think Outside is now Mitta AS, a subsidiary fully owned by Mitta Oy. Mitta will be offering geodata monitoring and measurement services to the Norwegian market, bridging the growth of the Finnish and Swedish Mitta companies to new Norwegian customers. For us at Mitta, accurate and reliable positioning is extremely important, as it is a basic prerequisite for spatial information. High-quality input data means cost-effectiveness in design, construction and monitoring, regardless of the customer's industry. Mitta is the market leader as a producer and processor of terrain information in the infrastructure sector in Finland and Sweden. Our customers operate in the construction value chain from design to production.

A bio-and medtech Company developing and selling proprietary solutions for using oxygen in various applications. Currently focussing on beverages (water, sports- and isotonic drinks), wound healing, cosmetics and fish farming. Licensing platform technology for applying oxygent to other products. Oxy Solutions is a privately held Norwegian based biotech company that has developed and patented an innovative technology for highly oxygenating liquid. Oxy Solutions'​ core business and strategy is to develop, document, IP protect, and commercialize the technology primarily within wound healing. The company has an in-house R&D facility in Norway. The company has funding from the Norwegian Research Council. Oxy Solutions is in possession of patented technology that makes it possible to greatly increase the dissolved level of oxygen in water. Tests have indicated stable levels in excess of 70 mg/l, or approximately 10 times higher than previously thought possible.

Software is eating education. Technology is used to modernise education. TERP has redefined the concept of a book by making it interactive. In its easiest form interaction can be films and animations integrated in a book. Tests and feedback on learning is one step further. In its most complex form, interaction is customised books generated for each reader, based on mapped preferences used as input in algorithms. The first book using this technology will have 114,000 potential versions. The TERP technology is not only redefining the concept of a book. It is interrupting the value chain in the industry. The technology provides a new and dynamic way of distribution. Competitors trying to copy the technology, not only has to figure out the code, they must change the way of doing business.